Skip to content

Shouldice Hospital Outcome Study

Shouldice Hospital Outcome Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03986060
Enrollment
3000
Registered
2019-06-14
Start date
2019-06-17
Completion date
2024-05-02
Last updated
2022-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Brief summary

A prospective cohort study recruiting participants from the Shouldice Hospital. The study population consists of healthy patients electing to receive hernia surgery for a primary inguinal hernia on an inpatient basis. The goal of this study is to determine the incidence of hernia pain and its intensity as well as other related outcomes up to one year after primary unilateral inguinal hernia repair.

Interventions

None listed

Sponsors

York University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years

Inclusion criteria

* Provide signed and dated informed consent form. * Willing to comply with all study procedures and be available for the duration of the study (patients have fixed address, access to phone, email, internet, and/or a computer) * Male or female, aged 18 to 90 years. * Subjects having surgery on a primary unilateral inguinal hernia * In good general health as evidenced by medical history * Capable of speaking and reading English sufficiently well to complete the questionnaires

Exclusion criteria

* Surgery is deemed an emergency procedure (any obstruction, incarceration or irreducible hernias). * Other abdominal hernias being operated on at the same time or surgery is planned during the follow-up period (incisional and umbilical hernias) * If hernia recurs within the study period and there is a reoperation within the year * BMI \>40kg/m2 * Patients unable to understand English, written and spoken * Patients with collagen or connective tissue disorders * Local (site of surgery) or systemic infection * Any known diseases that impair nerve function * Patients who end up getting a mesh repair during surgery * Impairment of cognitive function (e.g. dementia) * Pregnancy or lactation * Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants with pain severity scores > zero at one yearone-year post surgeryBrief Pain Inventory - pain severity 0-10 numeric rating scale. Typically score \>= 4 corresponds to moderate-to severe pain severity
Proportion of participants with pain-related interference in multiple life domainsone-year post surgeryBrief Pain Inventory - pain interference
Proportion of participants with neuropathic pain symptomsone yearID Pain 6-items total score ranges from 0 to 6

Secondary

MeasureTime frameDescription
proportion of participants with significant symptoms of anxiety, depressionone-year post surgeryPatient Health Questionnaire for Depression and Anxiety - PHQ-4 total score range from 0-12; anxiety subscale 0-6; depression subscale 0-6. total score cutoffs: 0-2 normal; 3-5 mild; 6-8 moderate; 9-12 severe
Do pain preoperative and early postoperative pain catastrophizing scores predict pain incidence, severity, and/or interferenceone yearPain Catastrophizing Scale -4 item. Total score range: 0-16. There are no sub scales and no cut-offs for this scale
Do preoperative perceived stress scores predict pain incidence, severity, and/or interferenceone-yearStress Assessment Test - no norms at present. Scale developed by authors and being validated.
Does pre-operative resilience scores predict lower pain incidence, severity, and/or interferenceone-yearConnor-Davidson Resilience Scale-2. Total score ranges from 0-8. There are no clinical cut-offs for this scale

Countries

Canada

Contacts

Primary ContactJoel Katz, PhD
jkatz@yorku.ca9999999999
Backup ContactMarguerite Mainprize
research@shouldice.com905 889 1125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026